Clinical Trial Update: Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery [Phase 2]

View source ↗

Summary

Bevacizumab is being studied in a Phase 2 trial for ovarian cancer patients undergoing second-look surgery. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasms of Female Genital Organs, Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING